Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system.

Bruno GrassiAna Maria GómezLuis Eduardo CalliariDenise FrancoMarcela RaggioFrancisca RieraMatias CastroJennifer McVeanTim van den HeuvelArcelia ArrietaJavier CastañedaOhad Cohen

Published in: Diabetes, obesity & metabolism (2023)

Real-world Latin American MM780G users on average showed good glucose control, achieving international targets. Glycaemic control increased with every technology iteration of the MM system, providing more automation each time.

Keyphrases

type diabetes
machine learning
high throughput
metabolic syndrome
insulin resistance